Obesity, Diabetes and Gastrointestinal Malignancy: The Role of Metformin and Other Anti-Diabetic Therapy

Global Journal of Obesity, Diabetes and Metabolic Syndrome

doi 10.17352/2455-8583.000032

Full Text

Abstract

Available in

Date

Authors

Publisher

Peertechz Publications Private Limited

Related search

Gastrointestinal Electrical Neuromodulation for Functional Gastrointestinal Diseases, Obesity and Diabetes

Bioelectronic Medicine
2015English

Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Ghrelin, Diabetes and Obesity - Prospects for an Anti-Obesity Vaccine

JMS SKIMS
2011English

Increased Risk of Gastrointestinal Malignancy in Patients With Diabetes Mellitus and Correlations With Anti-Diabetes Drugs: A Nationwide Population-Based Study in Taiwan

Internal Medicine
Internal MedicineMedicine
2013English

Ocular Anti-Vegf Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

The Role of Gastrointestinal Peptides in the Pathogenesis and Treatment of Obesity

Medicina Fluminensis
Medicine
2019English

The Management of Gastrointestinal Stromal Tumors: A Model for Targeted and Multidisciplinary Therapy of Malignancy

Annual Review of Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Role of Gastrointestinal Hormones in Feeding Behavior and Obesity Treatment

Journal of Gastroenterology
Gastroenterology
2015English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy